In addition, we detected a higher SMAD9 expression in high-risk NB tissues compared with normal adrenal gland (AG) tissues, and SMAD9 expression was higher in MYCN-amp and MYCN-high NB tumors (Fig. 1D). This evidence concerns the gene SMAD9 and neuroblastoma.